Table 6. Incidence of Gross Morphological Abnormalities in Rat Fetuses after Treatment with Valproic Acid and in Combination with Antioxidants^a.

treatment groups	crown rump length (cm)	fetal growth retardation (cm)
N.C	3.2 ± 0.4	0.0 ± 0.00
D.C V.P (500 mg/kg)	0.73 ± 0.15	1.11 ± 0.35
V.P + Vit. C (500 mg + 2000 mg/kg)	1.25 ± 0.27	0.4 ± 0.22
V.P + Vit. C (500 mg + 8000 mg/kg)	1.71 ± 0.32	0.2 ± 0.13*
V.P + Se (500 mg + 100 μg/kg)	1.55 ± 0.25	0.2 ± 0.13*
V.P + Se (500 mg + 200 μg/kg)	0.49 ± 0.09	0.5 ± 0.22
V.P + G.S (500 mg + 300 mg/kg)	1.58 ± 0.28	0.4 ± 0.26
V.P + G.S (500 mg + 600 mg/kg)	1.96 ± 0.37*	0.0 ± 0.00**

^aData are represented as mean ± SEM, n = 10; *P < 0.05, **P < 0.01were given in comparison to the disease control group.